Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,456
Closed -$16.7K 2986
2024
Q3
$16.7K Buy
1,456
+119
+9% +$1.35K ﹤0.01% 1628
2024
Q2
$13.4K Hold
1,337
﹤0.01% 1469
2024
Q1
$15.7K Hold
1,337
﹤0.01% 1434
2023
Q4
$15.3K Hold
1,337
﹤0.01% 1438
2023
Q3
$15.4K Hold
1,337
﹤0.01% 1455
2023
Q2
$15.6K Hold
1,337
﹤0.01% 1451
2023
Q1
$15.9K Hold
1,337
﹤0.01% 1414
2022
Q4
$13.2K Hold
1,337
﹤0.01% 1456
2022
Q3
$12K Hold
1,337
﹤0.01% 1481
2022
Q2
$15K Hold
1,337
﹤0.01% 1825
2022
Q1
$15K Hold
1,337
﹤0.01% 1925
2021
Q4
$14K Hold
1,337
﹤0.01% 2059
2021
Q3
$14K Hold
1,337
﹤0.01% 2098
2021
Q2
$15K Hold
1,337
﹤0.01% 2064
2021
Q1
$16K Hold
1,337
﹤0.01% 2190
2020
Q4
$16K Buy
1,337
+800
+149% +$9.36K ﹤0.01% 2043
2020
Q3
$5K Hold
537
﹤0.01% 2210
2020
Q2
$6K Hold
537
﹤0.01% 2112
2020
Q1
$6K Sell
537
-67
-11% -$910 ﹤0.01% 2006
2019
Q4
$8K Hold
604
﹤0.01% 2076
2019
Q3
$9K Hold
604
﹤0.01% 1943
2019
Q2
$9K Buy
604
+61
+11% +$963 ﹤0.01% 1955
2019
Q1
$8K Buy
543
+213
+65% +$3.3K ﹤0.01% 1924
2018
Q4
$5K Sell
330
-996
-75% -$16.1K ﹤0.01% 2008
2018
Q3
$21K Hold
1,326
﹤0.01% 1558
2018
Q2
$22K Hold
1,326
﹤0.01% 1412
2018
Q1
$22K Hold
1,326
﹤0.01% 1360
2017
Q4
$23K Hold
1,326
﹤0.01% 1335
2017
Q3
$21K Sell
1,326
-700
-35% -$11.7K ﹤0.01% 1310
2017
Q2
$32K Buy
2,026
+316
+18% +$5.13K ﹤0.01% 1105
2017
Q1
$26K Sell
1,710
-785
-31% -$12.2K ﹤0.01% 1150
2016
Q4
$37K Buy
2,495
+1,450
+139% +$21.7K ﹤0.01% 949
2016
Q3
$16K Hold
1,045
﹤0.01% 1221
2016
Q2
$16K Buy
1,045
+100
+11% +$1.67K ﹤0.01% 1193
2016
Q1
$15K Buy
+945
New +$16.3K ﹤0.01% 1180

Other funds holding ORAN

Geneos Wealth Management's ORAN Position: Q4 2024 in Review

Geneos Wealth Management sold out of Orange (ORAN) in Q4 2024, closing a stake of 1,456 shares — an estimated $16.7K sold.

Geneos Wealth Management first reported a position in ORAN in Q1 2016 and held it in 35 quarters. The position peaked at $37K in Q4 2016. 46 funds tracked by Wall St. Rank hold ORAN as of Q4 2024.

  • Geneos Wealth Management reported no remaining Orange position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 1,456 Orange shares in Q4 2024, an estimated $16.7K.
  • Geneos Wealth Management first reported a position in Orange in Q1 2016 and held it in 35 quarters.
  • Geneos Wealth Management's Orange position peaked at $37K in Q4 2016.
  • 46 funds tracked by Wall St. Rank held Orange as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.